Advertisement

Topics

Catabasis: Wall-Street-Analysten bestätigen 72$-Kursziel

15:08 EDT 9 Jul 2019 | FinanzNachrichten

In einem Research-Update zum Monatsanfang Juli bestätigt die renommierte New Yorker Investmentbank Oppenheimer ihr Kursziel für unsere Aktie des Jahres Catabasis Pharmaceuticals (WKN: A2PBC0): Satt...

Original Article: Catabasis: Wall-Street-Analysten bestätigen 72$-Kursziel

NEXT ARTICLE

More From BioPortfolio on "Catabasis: Wall-Street-Analysten bestätigen 72$-Kursziel"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...